Towards development of a statistical framework to evaluate myotonic dystrophy type 1 mRNA biomarkers in the context of a clinical trial.
Kurkiewicz A, Cooper A, McIlwaine E, Cumming SA, Adam B, Krahe R, Puymirat J, Schoser B, Timchenko L, Ashizawa T, Thornton CA, Rogers S, McClure JD, Monckton DG.
Kurkiewicz A, et al. Among authors: ashizawa t.
PLoS One. 2020 Apr 14;15(4):e0231000. doi: 10.1371/journal.pone.0231000. eCollection 2020.
PLoS One. 2020.
PMID: 32287265
Free PMC article.